Scientific topics
Keywords
ITMO
Cyrille Delpierre PhD in Epidemiology
Course and current status
Education
2013 Habilitation à Diriger des Recherches
Paul Sabatier University, Toulouse III, France
2006 Ph. D in Epidemiology
Paul Sabatier University, Toulouse III, France
2002 Master in Clinical Epidemiology and Evaluation in health
Henri Poincaré University, Nancy, France
1998 Bachelor Degree in biology
Paul Sabatier University, Toulouse III, France
Positions
January 2021: Director of the Centre for Epidemiology and Research in POPulation health (CERPOP, UMR 1295)
January 2021: Co-director of EQUITY Team member of the CERPOP (UMR 1295)
January 2016: Director of EQUITY Team member of the CERPOP (UMR 1295)
December 2015: Senior Researcher, Inserm, UMR 1027
December 2008: Researcher, Inserm, UMR 558
2007-2008: Post-doctoral researcher, UMR 558
2006-07: Post-doctoral researcher, Harvard School of Public Health, department of Society, Human Development and Health (with Pr Lisa Berkman)
2002-2006: Doctoral studies in epidemiology, UMR 558, directed by Thierry Lang. PhD thesis on Late HIV diagnosis: risk factors in two national studies (ANRS-EN12-VESPA, NADIS)
Scientific summary
I am a senior researcher at the Institut national de la santé et de la recherche médicale (Inserm), I head the Centre for Epidemiology and Research in POPulation Health (CERPOP), and I co-lead the EQUITY research team which studies social inequalities in health. As an epidemiologist, my research focuses on the analysis of the mechanisms of the genesis of social inequalities in health over the life course, particularly in the field of chronic diseases (cancers, HIV). The general objective is to explain the social gradient in health: i) not only by physico-chemical exposures and health behaviours that are socially distributed, but also by psychosocial exposures that may differ according to social environment. In this context, I am interested in the mechanisms by which the social environment, in the broadest sense, is biologically embodied, how it can affect biological functioning and thus favour the development of long-term pathologies; ii) by socially distributed access to and care by the health system.
